CLAMASKIN
ActiveSummary
CLAMASKIN has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €151,723 and a net result of €2,722. Equity is growing by ~3.1% per year across the filed fiscal years. Its solvency ranks better than 44% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability54▼-20
Solvency82▲+6
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days acceptable
Liquidity ample (current ratio 4.51 against 2.87 in 2024; short-term debt: 9.2% and cash: 25.4% of total assets), and 43.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.6%
Return on assets
1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
24 d late
2024
18 d late
2023
20 d late
2022
15 d late
2021
34 d early
2020
40 d early
2019
52 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 8 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€151,723▲ 1.8%
2024 · €149,002
Total assets
€268,058▼ 8.9%
2024 · €294,112
Net result
€2,722▼ 76.8%
2024 · €11,721
Working capital
€86,544▲ 1.5%
2024 · €85,288
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€44,341▲ 25.1%€34,528▼ 22.1%€50,909▲ 47.4%€20,465▼ 59.8%€8,407▼ 58.9%
Net result€26,485within the sector's middle half▲ 29.5%€21,020within the sector's middle half▼ 20.6%€31,909within the sector's middle half▲ 51.8%€11,721below the sector's middle half▼ 63.3%€2,722below the sector's middle half▼ 76.8%
Equity€114,352within the sector's middle half▲ 30.1%€115,372within the sector's middle half▲ 0.9%€137,281within the sector's middle half▲ 19.0%€149,002within the sector's middle half▲ 8.5%€151,723within the sector's middle half▲ 1.8%
Total assets€297,105within the sector's middle half▼ 3.8%€304,208within the sector's middle half▲ 2.4%€274,884within the sector's middle half▼ 9.6%€294,112within the sector's middle half▲ 7.0%€268,058within the sector's middle half▼ 8.9%
Debt€182,753▼ 17.3%€188,836▲ 3.3%€137,603▼ 27.1%€145,111▲ 5.5%€116,334▼ 19.8%
Working capital€45,246within the sector's middle half▲ 161%€52,639within the sector's middle half▲ 16.3%€74,227within the sector's middle half▲ 41.0%€85,288within the sector's middle half▲ 14.9%€86,544within the sector's middle half▲ 1.5%
Solvency38.5%within the sector's middle half▲ 10.0pp37.9%within the sector's middle half▼ 0.6pp49.9%within the sector's middle half▲ 12.0pp50.7%within the sector's middle half▲ 0.7pp56.6%within the sector's middle half▲ 5.9pp
Current ratio1.76within the sector's middle half▲ 0.551.72within the sector's middle half▼ 0.043.47within the sector's middle half▲ 1.752.87within the sector's middle half▼ 0.614.51within the sector's middle half▲ 1.64
Return on assets (ROA)8.9%within the sector's middle half▲ 2.3pp6.9%below the sector's middle half▼ 2.0pp11.6%within the sector's middle half▲ 4.7pp4.0%below the sector's middle half▼ 7.6pp1.0%below the sector's middle half▼ 3.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 59% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €268,058
Fixed assets
€156,844 ▼ 3.8%
Current assets
€111,213 ▼ 15.1%
Equity and liabilities €268,058
Equity
€151,723 ▲ 1.8%
Debt
€116,334 ▼ 19.8%
Debt's share of the balance-sheet total falls from 49.3% to 43.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€16,091▼
2024 · €28,010
Cash flow
€10,406▼
2024 · €19,265
Debt to equity
0.77▼
2024 · 0.97
ROE
1.8%▼
2024 · 7.9%
Interest coverage
4.07▼
2024 · 6.68
Debt ≤ 1 year
€24,669▼
2024 · €45,724
Debt > 1 year
€91,665▼
2024 · €99,386
Income taxes
€2,309▼
2024 · €5,312
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 10,905 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
0.6%
went bankrupt
4.0%
stopped otherwise
95%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 10,905 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €15,286 | €14,139 | €7,545 | €7,545 | €7,684 | ▲ 1.8% |
| Other operating charges640/8 | €1,501 | €1,527 | €1,676 | €2,028 | €1,779 | ▼ 12.3% |
| Gross operating margin9900 | €61,128 | €50,194 | €60,131 | €30,038 | €17,870 | ▼ 40.5% |
| Operating profit (loss)9901 | €44,341 | €34,528 | €50,909 | €20,465 | €8,407 | ▼ 58.9% |
| Financial income75/76B | - | €9 | €135 | €761 | €581 | ▼ 23.7% |
| Recurring financial income75 | - | €9 | €135 | €761 | €581 | ▼ 23.7% |
| Financial charges65/66B | €4,228 | €4,154 | €3,484 | €4,194 | €3,957 | ▼ 5.6% |
| Recurring financial charges65 | €4,228 | €4,154 | €3,484 | €4,194 | €3,957 | ▼ 5.6% |
| Profit (loss) for the period before taxes9903 | €40,113 | €30,383 | €47,561 | €17,032 | €5,031 | ▼ 70.5% |
| Income taxes67/77 | €13,628 | €9,363 | €15,652 | €5,312 | €2,309 | ▼ 56.5% |
| Profit (loss) for the period9904 | €26,485 | €21,020 | €31,909 | €11,721 | €2,722 | ▼ 76.8% |
| Profit (loss) for the period to be appropriated9905 | €26,485 | €21,020 | €31,909 | €11,721 | €2,722 | ▼ 76.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €297,105 | €304,208 | €274,884 | €294,112 | €268,058 | ▼ 8.9% |
| Fixed assets21/28 | €192,445 | €178,306 | €170,645 | €163,100 | €156,844 | ▼ 3.8% |
| Tangible fixed assets22/27 | €192,445 | €178,306 | €170,645 | €163,100 | €156,844 | ▼ 3.8% |
| Land and buildings22 | €185,040 | €177,692 | €170,343 | €162,995 | €155,646 | ▼ 4.5% |
| Plant, machinery and equipment23 | €927 | €614 | €301 | €105 | €0 | ▼ 100% |
| Furniture and vehicles24 | €6,478 | - | - | - | €1,198 | - |
| Current assets29/58 | €104,660 | €125,902 | €104,239 | €131,012 | €111,213 | ▼ 15.1% |
| Amounts receivable within one year40/41 | €22,565 | €21,281 | €21,511 | €38,878 | €39,502 | ▲ 1.6% |
| Trade receivables40 | €19,910 | €15,758 | €16,366 | €25,562 | €16,490 | ▼ 35.5% |
| Other amounts receivable41 | €2,655 | €5,523 | €5,145 | €13,315 | €23,013 | ▲ 72.8% |
| Cash at bank and in hand54/58 | €80,310 | €101,572 | €77,591 | €87,513 | €68,180 | ▼ 22.1% |
| Deferred charges and accrued income490/1 | €1,785 | €3,049 | €5,136 | €4,622 | €3,532 | ▼ 23.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €297,105 | €304,208 | €274,884 | €294,112 | €268,058 | ▼ 8.9% |
| Equity10/15 | €114,352 | €115,372 | €137,281 | €149,002 | €151,723 | ▲ 1.8% |
| Contributions10/11 | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Outside capital11 | €12,400 | €12,400 | - | - | - | - |
| Other1109/19 | €12,400 | €12,400 | - | - | - | - |
| Reserves13 | €82,160 | €82,910 | €104,760 | €115,760 | €118,460 | ▲ 2.3% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €0 | - | - | - |
| Legal reserve130 | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | - | - | €0 | - | - | - |
| Distributable reserves133 | €80,300 | €81,050 | €104,760 | €115,760 | €118,460 | ▲ 2.3% |
| Profit (loss) carried forward14 | €19,792 | €20,062 | €20,121 | €20,842 | €20,863 | ▲ 0.1% |
| Amounts payable17/49 | €182,753 | €188,836 | €137,603 | €145,111 | €116,334 | ▼ 19.8% |
| Amounts payable after more than one year17 | €123,339 | €115,573 | €107,591 | €99,386 | €91,665 | ▼ 7.8% |
| Financial debts170/4 | €123,339 | €115,573 | €107,591 | €99,386 | €91,665 | ▼ 7.8% |
| Amounts payable within one year42/48 | €59,414 | €73,263 | €30,012 | €45,724 | €24,669 | ▼ 46.0% |
| Current portion of amounts payable after more than one year42 | €13,868 | €7,766 | €7,982 | €8,185 | €8,415 | ▲ 2.8% |
| Financial debts43 | €1,000 | €1,013 | €2,127 | €1,287 | €1,265 | ▼ 1.7% |
| Credit institutions430/8 | €1,000 | €1,013 | €2,127 | €1,287 | €1,265 | ▼ 1.7% |
| Trade debts44 | €856 | €26 | €87 | €13,289 | €401 | ▼ 97.0% |
| Suppliers440/4 | €856 | €26 | €87 | €13,289 | €401 | ▼ 97.0% |
| Taxes, remuneration and social security45 | €5,400 | €15,950 | €5,585 | €6,685 | €2,670 | ▼ 60.1% |
| Taxes450/3 | €4,075 | €8,775 | €5,585 | €6,685 | €2,670 | ▼ 60.1% |
| Remuneration and social security454/9 | €1,325 | €7,175 | €0 | - | - | - |
| Other amounts payable47/48 | €38,290 | €48,508 | €14,230 | €16,278 | €11,918 | ▼ 26.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €26,485 | €21,020 | €31,909 | €11,721 | €2,722 | ▼ 76.8% |
| + Depreciation and write-downs630 | €15,286 | €14,139 | €7,545 | €7,545 | €7,684 | ▲ 1.8% |
| Operating cash flow (approximation) | €41,771 | €35,159 | €39,454 | €19,265 | €10,406 | ▼ 46.0% |
| Investment in fixed assets (approximation) | - | €0 | €116 | €0 | -€1,428 | - |
| Change in cash | - | €21,262 | -€23,981 | €9,921 | -€19,333 | ▼ 295% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 24 days late
2025
31-12
Financial
Weakest financial yearnet €2,722 ▼76.8%
Net result drops to €2,722, the lowest in the series.
31-12
Financial
Equity above €150,000Eq €151,723 ▲1.8%
8 profitable years in a row build equity to €151,723.
18-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 18 days late
2024
20-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 20 days late
2023
31-12
Financial
Highest result since 2018net €31,909 ▲51.8%
Operating result €50,909, net result €31,909, both a record.
31-12
Financial
Liquidity doublescurrent ratio 3.47
Current ratio from 1.72 to 3.47; short-term debt falls from €73,263 to €30,012.
15-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 15 days late
2022
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €100,000Eq €114,352 ▲30.1%
4 profitable years in a row build equity to €114,352.
21-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
21-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 52 days late
Show earlier events
2019
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
09-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 9 days late
2017
18-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genappe · 1 establishment unit since 2008
Ground area
4,766 m²
Building footprint
310 m²
Volume, LiDAR
1,811 m³
2 parcels, Wallonia · tallest building 9.3 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Clamaskin
since 20082.255.269.497
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25013E0053/00B000 | Wallonia | 4,420 m² | 1 · 263 m² | 8.2 m · 2 fl. |
| 25743F0109/00V000 | Wallonia | 346 m² | 1 · 47 m² | 9.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SKIN-LION
BE 0556.729.421
Beloeil · Eq €151,707
Associatie Lux
BE 0717.976.182
Leuven · Eq €151,674
DR. TOM VAN DEN LANGENBERGH
BE 0727.958.571
Kapellen · Eq €151,805
LA MAISON DES DOCTEURS
BE 0794.359.130
Seneffe · Eq €151,606
DOKTERSHUIS ANTWERPEN
BE 0660.789.833
Antwerpen · Eq €151,545
Of 16,631 companies in sector 86220 we hold annual accounts for 7,986. 6,762 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded09-07-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0899170303
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.